New malaria treatment paves way for eradication The US authorities have approved the first new treatment in 60 years for malaria that is endemic in Asia and Latin America.
Experts hope it will play a significant role in eliminating the mosquito-borne disease, which is on the march again after decades of decline.
The US Food and Drug Administration has approved the drug tafenoquine for the treatment of Plasmodium vivax malaria - a disease causing around 8.5million infections every year in Asia, Latin America and parts of Africa. The Daily Telegraph
See also:
Experts hope it will play a significant role in eliminating the mosquito-borne disease, which is on the march again after decades of decline.
The US Food and Drug Administration has approved the drug tafenoquine for the treatment of Plasmodium vivax malaria - a disease causing around 8.5million infections every year in Asia, Latin America and parts of Africa. The Daily Telegraph
See also:
No comments:
Post a Comment